Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02357979 · ClinicalTrials.gov registry record · NA

Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02357979: Completed NA study, sponsored by University of California, San Francisco.

NCT02357979 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02357979, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The objective of this clinical study is to evaluate whether the use of the new CO2 - 9.3μm short-pulsed laser increases the caries resistance of occlusal pit and fissure surfaces in patients in addition to fluoride therapy. This will be quantified by visual exams with the International Caries Detection and Assessment System (ICDAS II), SOPROLIFE daylight and blue fluorescence, and DIAGNOdent Laser Light-induced Fluorescence. This is a randomized, single blind, prospective, split mouth controlled, clinical trial over 12 months.

Primary Outcome

Difference in number of lesion changes into ICDAS score 3 (signifying a cavity) between matched case and control teeth (within patient) from baseline to 6 months and baseline to 12 months. The International Caries Detection and Assessment System (ICDAS) is a visual assessment of the caries levels. The ICDAS score ranges from 0 to 6, with score 0 meaning no demineralization at all, score 3 means a first physical loss of enamel, and score 6 means a huge cavity.

Interventions

  • DEVICE Laser
  • OTHER Fluoride

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-02-08
Est. Completion 2020-03-31
Phase NA

What the finished NCT02357979 record still lists

NCT02357979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Laser is the first listed.

NCT02357979 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02357979 about?

NCT02357979 is a clinical study titled "Fissure Caries Inhibition Study With Solea CO2-9.3μm Short-pulsed Laser". The objective of this clinical study is to evaluate whether the use of the new CO2 - 9.3μm short-pulsed laser increases the caries resistance of occlusal pit and fissure surfaces in patients in addition to fluoride therapy. This will be quantified by visual exams with the International Caries Detect...

What is the current status of trial NCT02357979?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-02-08. Estimated completion is 2020-03-31.

What interventions are being tested in trial NCT02357979?

The interventions under investigation include: Laser (DEVICE), Fluoride (OTHER).

Who is sponsoring clinical trial NCT02357979?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02357979's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02357979, the US trial registry maintained by the National Library of Medicine. NCT02357979 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.